 Katherine Frasca
Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual and Gender Minorities | 3 | 2022 | 259 | 1.360 |
Why?
| | HIV Infections | 8 | 2022 | 3193 | 1.250 |
Why?
| | Anti-HIV Agents | 6 | 2022 | 912 | 1.110 |
Why?
| | Pre-Exposure Prophylaxis | 3 | 2022 | 269 | 0.770 |
Why?
| | Coinfection | 2 | 2014 | 143 | 0.760 |
Why?
| | Community Health Services | 2 | 2014 | 231 | 0.740 |
Why?
| | Tuberculosis | 2 | 2014 | 283 | 0.670 |
Why?
| | AIDS Serodiagnosis | 1 | 2018 | 23 | 0.560 |
Why?
| | Drug Monitoring | 2 | 2019 | 401 | 0.540 |
Why?
| | Dried Blood Spot Testing | 1 | 2019 | 126 | 0.540 |
Why?
| | Emtricitabine | 1 | 2019 | 210 | 0.520 |
Why?
| | Viral Load | 1 | 2019 | 526 | 0.490 |
Why?
| | Sexual Behavior | 1 | 2019 | 494 | 0.430 |
Why?
| | Program Evaluation | 1 | 2019 | 943 | 0.430 |
Why?
| | Vancomycin Resistance | 1 | 2012 | 16 | 0.380 |
Why?
| | Oxazolidinones | 1 | 2012 | 17 | 0.380 |
Why?
| | Enterococcus | 1 | 2012 | 22 | 0.370 |
Why?
| | Acetamides | 1 | 2012 | 41 | 0.370 |
Why?
| | Meningitis, Bacterial | 1 | 2012 | 46 | 0.360 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2012 | 71 | 0.350 |
Why?
| | Curriculum | 1 | 2019 | 1070 | 0.350 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2014 | 303 | 0.330 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 232 | 0.310 |
Why?
| | Zidovudine | 1 | 2009 | 77 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1419 | 0.300 |
Why?
| | Homosexuality, Male | 2 | 2022 | 231 | 0.280 |
Why?
| | Internship and Residency | 1 | 2019 | 1267 | 0.270 |
Why?
| | Infant, Newborn, Diseases | 1 | 2009 | 115 | 0.270 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2009 | 194 | 0.260 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2012 | 699 | 0.240 |
Why?
| | Colchicine | 1 | 2024 | 21 | 0.210 |
Why?
| | Pericarditis | 1 | 2024 | 11 | 0.210 |
Why?
| | Chest Pain | 1 | 2024 | 99 | 0.200 |
Why?
| | Salmonella Infections | 1 | 2024 | 57 | 0.200 |
Why?
| | Myocarditis | 1 | 2024 | 102 | 0.190 |
Why?
| | Antitubercular Agents | 2 | 2014 | 208 | 0.180 |
Why?
| | Philadelphia | 2 | 2018 | 55 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 345 | 0.170 |
Why?
| | HIV Seronegativity | 1 | 2018 | 29 | 0.140 |
Why?
| | Medication Adherence | 1 | 2022 | 540 | 0.130 |
Why?
| | Health Surveys | 1 | 2018 | 518 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2121 | 0.120 |
Why?
| | Africa South of the Sahara | 1 | 2014 | 54 | 0.110 |
Why?
| | Humans | 10 | 2024 | 145474 | 0.110 |
Why?
| | Self Report | 1 | 2019 | 870 | 0.110 |
Why?
| | Medicaid | 1 | 2018 | 467 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1923 | 0.100 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 297 | 0.100 |
Why?
| | Linezolid | 1 | 2012 | 25 | 0.090 |
Why?
| | Female | 6 | 2022 | 78844 | 0.090 |
Why?
| | Male | 6 | 2024 | 72842 | 0.090 |
Why?
| | Adult | 4 | 2019 | 40777 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 881 | 0.090 |
Why?
| | Middle Aged | 4 | 2019 | 36215 | 0.090 |
Why?
| | Transplantation, Autologous | 1 | 2012 | 300 | 0.090 |
Why?
| | Immunocompromised Host | 1 | 2012 | 202 | 0.080 |
Why?
| | Age Factors | 1 | 2018 | 3342 | 0.080 |
Why?
| | Adolescent | 2 | 2022 | 22529 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2022 | 17291 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1371 | 0.070 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 782 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5904 | 0.060 |
Why?
| | Prospective Studies | 1 | 2019 | 8057 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2014 | 1101 | 0.060 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2009 | 440 | 0.050 |
Why?
| | Young Adult | 1 | 2018 | 14218 | 0.040 |
Why?
| | Electrocardiography | 1 | 2024 | 665 | 0.040 |
Why?
| | United States | 1 | 2018 | 16098 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1508 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2009 | 6447 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 11772 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 7202 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2016 | 288 | 0.030 |
Why?
|
|
Frasca's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|